Posted in | News | Business | Petrochemicals

BASF to Sell Share in Ethane Cracker

BASF Corporation today announced that it has agreed to sell its minority ownership interest in a 610,000 tons per year ethane cracker and associated pipeline and storage facilities located in Geismar, Louisiana. Subject to regulatory approvals, Williams Olefins, L.L.C., will purchase BASF's ownership interest in the cracker and PetroLogistics, LLC, will purchase BASF's interest in the associated pipeline and storage facilities. Terms of the agreements were not disclosed. Closing is expected to take place in July.

The ethane cracker is jointly owned by GE Petrochemicals, Williams Olefins, L.L.C. and BASF, and operated by Williams Olefins, L.L.C. The pipeline and storage facilities are jointly owned by GE Petrochemicals, PetroLogistics, LLC, and BASF, and operated by PetroLogistics.

BASF purchased its ownership stake in the cracker and associated facilities in 1970 as part of its acquisition of Wyandotte Chemicals. Each owner supplies raw materials to the cracker and independently markets its share of production from the cracker.

"BASF's strategy to more closely balance olefins supply capability with captive demand is well served by our world-scale joint venture naphtha steam cracker in Port Arthur, Texas, reducing the strategic importance of the Geismar ethane cracker to BASF," said Peter Cella, NAFTA Group Vice President, Petrochemicals. "We believe our investment in the Port Arthur cracker and the latest technology deployed at this facility will provide BASF with a sustainable first quartile competitive position in the marketplace."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.